NCT06041035 2023-09-18
A Study of QLS31905 Combination Chemotherapy as First-Line Treatment in Patients With Advanced Solid Tumors
Qilu Pharmaceutical Co., Ltd.
Phase 1/2 Unknown
Clinical Trials
10 trialsNCT05218148 2022-04-06
SOX Combined With Sintilimab and Trastuzumab Versus SOX Regimen in the Perioperative Treatment of HER2-positive Locally Advanced Gastric Adenocarcinoma
ChineseAMS
Phase 2 Unknown
NCT04802980 2021-07-28
A Study of HB002.1T Plus Chemotherapy in Subjects With Solid Tumor
Huabo Biopharm Co., Ltd.
Phase 1 Unknown
NCT02435927 2021-04-28
ASLAN001 in Combination With Oxaliplatin and Capecitabine or Oxaliplatin and 5-FU With Leucovorin
National Cancer Centre, Singapore
Phase 1 Unknown
NCT03503604 2018-04-20
A Study of Anti-VEGF Monoclonal Antibody hPV19 in Patients With Solid Tumors
SuZhou Stainwei Biotech Inc.
Phase 1 Unknown
NCT00004173 2013-05-15
Oxaliplatin and Paclitaxel in Treating Patients With Metastatic or Unresectable Cancer
National Cancer Institute (NCI)
Phase 1 Unknown
NCT01558453 2013-03-26
Oxaliplatin for Children With Solid Tumors
Hospital Santa Marcelina
Phase 2 Unknown
NCT00996385 2011-10-31
Velcade and Eloxatin for Patients With Malignant Pleural or Peritoneal Mesothelioma
Columbia University
Phase 2 Unknown
NCT00544063 2009-12-15
Capecitabine, Irinotecan, and Oxaliplatin in Treating Patients With Metastatic Cancer
National Cancer Institute (NCI)
Phase 1 Unknown
NCT00274859 2008-07-24
Gemcitabine and Oxaliplatin in Treating Patients With Metastatic Cancer
National Cancer Institute (NCI)
Phase 2 Unknown